A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients
Neil Singla, Amy Rock, Leo Pavliv, Neil Singla, Amy Rock, Leo Pavliv
Abstract
Objective: To determine whether pre- and post-operative administration of intravenous ibuprofen (IV-ibuprofen) can significantly decrease pain and morphine use when compared with placebo in adult orthopedic surgical patients.
Design: This was a multi-center, randomized, double-blind placebo-controlled trial.
Setting: This study was completed at eight hospitals; six in the United States and two in South Africa.
Patients: A total of 185 adult patients undergoing elective orthopedic surgery.
Interventions: Patients were randomized to receive either 800 mg IV-ibuprofen or placebo every 6 hours, with the first dose administered pre-operatively. Additionally, all patients had access to intravenous morphine for rescue.
Outcome measures: Efficacy of IV-ibuprofen was demonstrated by measuring the patient's self assessment of pain using a visual analog scale (VAS; assessed with movement and at rest) and a verbal response scale (VRS). Morphine consumption during the post-operative period was also assessed.
Results: In the immediate post-operative period, there was a 25.8% reduction in mean area under the curve-VAS assessed with movement (AUC-VASM) in patients receiving IV-ibuprofen (P < 0.001); a 31.8% reduction in mean AUC-VAS assessed at rest (AUC-VASR; P < 0.001) and a 20.2% reduction in mean VRS (P < 0.001) compared to those receiving placebo. Patients receiving IV-ibuprofen used 30.9% less morphine (P < 0.001) compared to those receiving placebo. Similar treatment emergent adverse events occurred in both study groups and there were no significant differences in the incidence of serious adverse events.
Conclusion: Pre- and post-operative administration of IV-ibuprofen significantly reduced both pain and morphine use in orthopedic surgery patients in this prospective randomized placebo-controlled trial.
Figures
References
- Practice guidelines for acute pain management in the perioperative setting. A report by the American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section. Anesthesiology. 1995;82:1071–81.
- Carr DB, Miaskowski C, Dedrick SC, Williams GR. Management of perioperative pain in hospitalized patients: A national survey. J Clin Anesth. 1998;10:77–85.
- Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–56.
- Southworth S. A multicenter, randomized, double-blind, placebo-controlled trial intravenous ibuprofen for the management of postoperative pain in adults. Clin Ther. 2009;31(9):1922–35.
- Macintyre P, Jarvis D. Age is the best predictor of postoperative morphine requirements. Pain. 1996;64:357–64.
- Hintze J. NCSS and PASS Number Cruncher Statistical Systems. Kaysville, UT: NCSS; 2004.
- Guidelines for Industry: Statistical Principles for Clinical Trials (E9) 1998. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, September.
- Beunckens C, Molenberghs G, Kenward MG. Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials. 2005;2(5):379–86.
- Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97:534–40. table of contents.
- Ketorolac Package Insert/Product Labeling, Baxter Healthcare Corporation, 2008.
Source: PubMed